Quarterly report · Q2

Period2023-07-01 → 2023-12-31
Filed2024-02-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
MetricValuePeriodScopeSource row
Revenue¥126.7bn2023-07-01 → 2023-12-31Cons.Net sales
Revenue¥239.1bn2022-07-01 → 2023-06-30Cons.Net sales (5-year summary)
Revenue¥118.3bn2022-07-01 → 2022-12-31Cons.Net sales
Operating income¥681m2023-07-01 → 2023-12-31Cons.Operating income
Operating income¥1.1bn2022-07-01 → 2022-12-31Cons.Operating income
Ordinary income¥900m2023-07-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥2.4bn2022-07-01 → 2023-06-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥1.3bn2022-07-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥895m2023-07-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥1.4bn2022-07-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥505m2023-07-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥1.5bn2022-07-01 → 2023-06-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥859m2022-07-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥505m2023-07-01 → 2023-12-31Cons.Profit loss
Net income¥859m2022-07-01 → 2022-12-31Cons.Profit loss
Total assets¥112.6bnat 2023-12-31Cons.Assets
Total assets¥97.5bnat 2023-06-30Cons.Assets
Total assets¥99.5bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥94.0bnat 2023-12-31Cons.Liabilities
Total liabilities¥78.9bnat 2023-06-30Cons.Liabilities
Net assets / equity¥18.6bnat 2023-12-31Cons.Net assets
Net assets / equity¥18.6bnat 2023-06-30Cons.Net assets
Net assets / equity¥17.5bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥14.0bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥10.3bnat 2023-06-30Cons.Cash and deposits
Cash & equivalents¥14.0bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥10.3bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥8.9bnat 2022-12-31Cons.Cash and cash equivalents
Cash & equivalents¥9.1bnat 2022-06-30dCons.Cash and cash equivalents
Operating cash flow−¥1.5bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in operating activities
Operating cash flow¥1.2bn2022-07-01 → 2023-06-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥3.3bn2022-07-01 → 2022-12-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥1.5bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥863m2022-07-01 → 2023-06-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥291m2022-07-01 → 2022-12-31Cons.Net cash provided by used in investment activities
Financing cash flow¥6.7bn2023-07-01 → 2023-12-31Cons.Net cash provided by used in financing activities
Financing cash flow¥863m2022-07-01 → 2023-06-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥3.5bn2022-07-01 → 2022-12-31Cons.Net cash provided by used in financing activities
EPS (basic)¥23.032023-07-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥18.782023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥68.322022-07-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥39.192022-07-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥24.82022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥22.932023-07-01 → 2023-12-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥68.092022-07-01 → 2023-06-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥39.072022-07-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio16.5%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio19.1%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio17.6%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-07-01 → 2023-12-31−¥7m
Reconciling Itemsreconcilingrevenue intersegment2023-07-01 → 2023-12-31−¥7m
Reconciling Itemsreconcilingsegment profit2023-07-01 → 2023-12-31−¥4.2bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue2023-07-01 → 2023-12-31¥123.8bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue external2023-07-01 → 2023-12-31¥123.8bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue intersegment2023-07-01 → 2023-12-31¥7m
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentsegment profit2023-07-01 → 2023-12-31¥4.6bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentrevenue2023-07-01 → 2023-12-31¥2.9bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentrevenue external2023-07-01 → 2023-12-31¥2.9bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentsegment profit2023-07-01 → 2023-12-31¥201m
Total Of Reportable Segments And Otherssegment totalrevenue2023-07-01 → 2023-12-31¥126.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-07-01 → 2023-12-31¥126.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-07-01 → 2023-12-31¥7m
Total Of Reportable Segments And Otherssegment totalsegment profit2023-07-01 → 2023-12-31¥4.8bn
Reconciling Itemsreconcilingrevenue2022-07-01 → 2022-12-31−¥81,000
Reconciling Itemsreconcilingrevenue intersegment2022-07-01 → 2022-12-31−¥81,000
Reconciling Itemsreconcilingsegment profit2022-07-01 → 2022-12-31−¥3.7bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue2022-07-01 → 2022-12-31¥115.6bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue external2022-07-01 → 2022-12-31¥115.6bn
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentrevenue intersegment2022-07-01 → 2022-12-31¥81,000
jpcrp040300-q2r_E22995-000Medical Equipment Salesreportable segmentsegment profit2022-07-01 → 2022-12-31¥4.6bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentrevenue2022-07-01 → 2022-12-31¥2.7bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentrevenue external2022-07-01 → 2022-12-31¥2.7bn
jpcrp040300-q2r_E22995-000Nursing Care And Welfarereportable segmentsegment profit2022-07-01 → 2022-12-31¥197m
Total Of Reportable Segments And Otherssegment totalrevenue2022-07-01 → 2022-12-31¥118.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-07-01 → 2022-12-31¥118.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-07-01 → 2022-12-31¥81,000
Total Of Reportable Segments And Otherssegment totalsegment profit2022-07-01 → 2022-12-31¥4.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 550
ItemContextValueUnit
Number of shares heldCurrentQuarterInstant_No1MajorShareholdersMember2190000
Shareholding ratioCurrentQuarterInstant_No1MajorShareholdersMember0.100
Number of shares heldCurrentQuarterInstant_No2MajorShareholdersMember2188000
Shareholding ratioCurrentQuarterInstant_No2MajorShareholdersMember0.100
Number of shares heldCurrentQuarterInstant_No3MajorShareholdersMember1920000
Shareholding ratioCurrentQuarterInstant_No3MajorShareholdersMember0.088
Number of shares heldCurrentQuarterInstant_No4MajorShareholdersMember1410000
Shareholding ratioCurrentQuarterInstant_No4MajorShareholdersMember0.064
Number of shares heldCurrentQuarterInstant_No5MajorShareholdersMember1131000
Shareholding ratioCurrentQuarterInstant_No5MajorShareholdersMember0.052
Number of shares heldCurrentQuarterInstant_No6MajorShareholdersMember592000
Shareholding ratioCurrentQuarterInstant_No6MajorShareholdersMember0.027
Number of shares heldCurrentQuarterInstant_No7MajorShareholdersMember433000
Shareholding ratioCurrentQuarterInstant_No7MajorShareholdersMember0.020
Number of shares heldCurrentQuarterInstant_No8MajorShareholdersMember396000
Shareholding ratioCurrentQuarterInstant_No8MajorShareholdersMember0.018
Number of shares heldCurrentQuarterInstant_No9MajorShareholdersMember382000
Shareholding ratioCurrentQuarterInstant_No9MajorShareholdersMember0.017
Number of shares heldCurrentQuarterInstant_No10MajorShareholdersMember370000
Shareholding ratioCurrentQuarterInstant_No10MajorShareholdersMember0.017
Number of shares heldCurrentQuarterInstant11015000
Shareholding ratioCurrentQuarterInstant0.502
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsCurrentQuarterInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember900
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember21916400
Number of voting rights issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember219164
Number of shares issued shares voting rightsCurrentQuarterInstant_OrdinarySharesSharesLessThanOneUnitMember7804
Number of shares issued shares voting rightsCurrentQuarterInstant21925104
Number of voting rights issued shares voting rightsCurrentQuarterInstant219164
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row1Member900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row1Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row1Member900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row1Member0.000
Number of shares held in own name treasury shares etcCurrentQuarterInstant900
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant900
Shareholding ratio treasury shares etcCurrentQuarterInstant0.000
Cash and depositsPrior1YearInstant10330262000JPY
Cash and depositsCurrentQuarterInstant14028736000JPY
Notes and accounts receivable tradePrior1YearInstant50267866000JPY
Notes and accounts receivable tradeCurrentQuarterInstant60129205000JPY
Merchandise and finished goodsPrior1YearInstant11845054000JPY
Merchandise and finished goodsCurrentQuarterInstant12888005000JPY
Raw materials and suppliesPrior1YearInstant12027000JPY
Raw materials and suppliesCurrentQuarterInstant24440000JPY
Other caPrior1YearInstant3877922000JPY
Other caCurrentQuarterInstant3733621000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-06-30pass
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2022-07-01/2022-12-31pass
statement vs summary · operating cash flowconsolidated 2023-07-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-07-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-07-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass